Company profile
Adjuvance Technologies company profile
Adjuvance is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. Adjuvants are critical components that are added to many vaccines to improve the immune response.
Business identity
- Phone number
- 4028175050
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2009-07-08
Headquarters
- Headquarters
- Fennville, Michigan, United States
- Country code
- US
- Continent
- North America